Company
ChinaHumanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd., Wuhan, China – FDA Inspections
Inspection records and compliance data for Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. in Wuhan. 4 FDA inspections on record, 2 Form 483s, last inspected March 07, 2025.
Company Profile
This profile covers Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. based in Wuhan, China.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected May 22, 2015. Last inspected March 7, 2025.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 7, 2025 | Not classified | Human Drugs | 1267158 |
| June 14, 2019 | VAI | Human Drugs · Drug Quality Assurance | 1106763 |
| September 15, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1032045 |
| May 22, 2015 | NAI | Human Drugs · Drug Quality Assurance | 931632 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Kingkey MBC Life Technology Group Co., Ltd.
Yabao Pharmaceutical Co., Ltd. Beijing
Mayo Clinic PET Radiochemistry Facility
Biologische Heilmittel Heel Gmbh
Zep Inc
K Patel Phyto Extractions Private Ltd
ABC Compounding Co., Inc.
Novo Nordisk Pharmaceutical Industries LP
Vils Pharma Coating, LLC
CSL Plasma Inc.
Company Information
Name
Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.
FEI Number
3010163919
Address
No. 99 2nd Shendun Road, East Lake, Technology Development Zone, Wuhan, China
Country
China
ID: 0e692896-3bde-46a7-95ed-e65be70624d2